ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese mice

Autor: Maria Esmeria Corezola do Amaral, Antonio C. Boschero, Sara T. Olalla-Saad, Gabriela Moreira Soares, Jean Franciesco Vettorazzi, Helena C. Barbosa-Sampaio, Everardo M. Carneiro, Lucas Zangerolamo
Rok vydání: 2019
Předmět:
Zdroj: Canadian Journal of Physiology and Pharmacology. 97:1018-1027
ISSN: 1205-7541
0008-4212
DOI: 10.1139/cjpp-2018-0691
Popis: ARHGAP21 is a Rho-GAP that controls GTPases activity in several tissues, but its role on liver lipid metabolism is unknown. Thus, to achieve the Rho-GAP role in the liver, control and ARHGAP21-haplodeficient mice were fed chow (Ctl and Het) or high-fat diet (Ctl-HFD and Het-HFD) for 12 weeks, and pyruvate and insulin tolerance tests, insulin signaling, liver glycogen and triglycerides content, gene and protein expression, and very-low-density lipoprotein secretion were measured. Het mice displayed reduced body weight and plasma triglycerides levels, and increased liver insulin signaling. Reduced gluconeogenesis and increased glycogen content were observed in Het-HFD mice. Gene and protein expression of microsomal triglyceride transfer protein were reduced in both Het mice, while the lipogenic genes SREBP-1c and ACC were increased. ARHGAP21 knockdown resulted in hepatic steatosis through increased hepatic lipogenesis activity coupled with decreases in CPT1a expression and very-low-density lipoprotein export. In conclusion, liver of ARHGAP21-haplodeficient mice are more insulin sensitive, associated with higher lipid synthesis and lower lipid export.
Databáze: OpenAIRE